1 Bjs 10662
1 Bjs 10662
1 Bjs 10662
Presented to a meeting of the International Hepato-Pancreato-Biliary Association, São Paulo, Brazil, April 2016;
published in abstract form as HPB 2016; 18: e3–e4
work2 – 6 . Although a recent study7 from a high-volume surgery, blood loss, complication rate (using definitions of
centre reported concerns about greater morbidity for the the International Study Group of Pancreatic Surgery and
laparoscopic approach, with a higher pancreatic fistula the Clavien–Dindo classification)10 – 13 , and pathological
rate, a meta-analysis8 including more than 20 000 patients radicality of resection.
revealed favourable outcomes in well selected patients in At the interim analysis, the primary outcome variable
centres with a larger volume. was changed from complication rate to hospital stay, given
Although current reports from various centres support the insufficient sample size. The protocol was modified
use of laparoscopic resection, the studies so far are case with the approval of the hospital institutional review board,
series, case-matched comparisons or non-randomized and subsequent changes notified to the trial registration
trials. A randomized trial analysing open versus laparo- authorities.
scopic pancreatoduodenectomy has not been reported8 . The CONSORT statement guidelines14 were followed
The present study was therefore carried out as an RCT for reporting of the results.
to determine whether the laparoscopic approach is com-
parable to open pancreatoduodenectomy in terms of
Randomization
hospital stay, complications, oncological safety and overall
short-term outcomes. Simple randomization was done using a random number
table, with opaque sealed envelopes. The allocation was
Methods made through the inpatient admission section after con-
firmation of resectability by cross-sectional imaging and
This study was conducted from September 2013 to August staging laparoscopy.
2015 at a tertiary-care teaching institute in India. It was
a single-centre, non-stratified, balanced allocation (1:1)
open-label, parallel-group RCT. The study protocol was Data collection and initial evaluation
approved by the hospital ethics committee and was regis- On admission, demographic and anthropometric data were
tered prospectively at ClinicalTrials.gov as the PLOT trial recorded along with a detailed clinical history. Patients
(Pancreatic Head and Periampullary Cancer Laparoscopic underwent complete physical examination followed by lab-
versus Open Surgical Treatment; NCT02081131). oratory and radiological investigations. After establish-
All procedures were carried out in accordance with the ing the diagnosis, tumours were staged according to the
ethical standards of the responsible committee on human TNM classification (7th edition)15 and were discussed in
experimentation (institutional) and with the Helsinki Dec- a multidisciplinary tumour board meeting. Patients with
laration of 1964 and later versions along with Good Clin- potentially resectable tumours and deemed fit for surgery
ical Practice. Informed consent was obtained from all were considered for staging laparoscopy. Informed con-
patients for inclusion in the study. sent was obtained from the patient and family regarding
participation in the study, the possibility of undergoing
Inclusion and exclusion criteria either of the mentioned procedures, complications, and
Patients of either sex, aged 30–70 years, with a diagnosis expected outcomes. All patients, irrespective of final oper-
of resectable9 periampullary (distal cholangiocarcinoma, or ation, had an epidural catheter placed before the proce-
duodenal, ampullary or pancreatic head) cancer were eli- dure; the top-up dose in the postoperative period was
gible. Included were those with no radiological involve- decided by an anaesthetist, according to individual patient’s
ment of the superior mesenteric vein and portal vein, requirements. Patients were randomized after confirma-
and preserved fat planes between the tumour and coeliac tion of non-metastatic status into either the laparoscopy or
axis, hepatic artery and superior mesenteric artery. Patients open surgery group. The patients were grouped and sub-
undergoing initial surgery without previous chemotherapy sequently analysed based on the original randomization, in
were eligible, as well as those with no metastatic disease accordance with the intention-to-treat principle, irrespec-
after staging laparoscopy. Excluded were those found to tive of their final treatment.
have unresectable disease at the outset and those found to
have unresectable disease at a later stage of the procedure. Need for preoperative drainage
Preoperative biliary drainage (PBD) was not carried out
Study outcomes
routinely. The arbitrary cut-off for PBD in the present
The primary outcome variable was duration of postoper- study was a total bilirubin level of more than 20 mg/dl,
ative hospital stay. Secondary outcomes were duration of or other indications such as the presence of cholangitis or
coagulopathy. The preferred method was by endoscopic discharge or death. The mean(s.d.) length of hospital stay
retrograde cholangiopancreatography with a plastic stent; for open pancreatoduodenectomy considered was 13(9⋅7)
if unsuccessful, percutaneous transhepatic biliary drainage days. Based on the authors’ experience and published
was used instead. Patients were considered for surgery only evidence, the mean length of hospital stay for laparo-
after the purpose of drainage had been achieved, that is scopic pancreatoduodenectomy was estimated at 6 days.
a bilirubin level of less than 5 mg/dl and freedom from To achieve a power of more than 80 per cent to detect
cholangitis; this usually took 3–4 weeks. differences in the two surgical groups and with a two-sided
test having a type I error of 0⋅05, with an effect size of
Surgery 7 days, it was calculated that 32 patients would be required
All the procedures were performed by either of the two in each group.
senior surgeons with sufficient experience of open and Continuous variables with a normal distribution are
laparoscopic pancreatoduodenectomy (more than 25 of reported as mean(s.d.) and those with a non-normal
each procedure). The hospital is a high-volume centre distribution as median (range). Student’s t test and
(over 40 pancreatoduodenectomies per year), with expe- Mann–Whitney U test respectively were used for analysis
rience of more than 150 procedures using a laparoscopic of these variables, and the χ2 test or Fisher’s exact test for
approach before the start of the present study16 . A verti- categorical variables. Variables with extreme values that
cal upper midline approach was preferred for open pan- skewed the data were analysed after omitting the outliers.
creatoduodenectomy and the procedure was performed in P < 0⋅050 was considered statistically significant. All sta-
accordance with the hospital protocol. A standard tech- tistical tests were done using SPSS® software version 17
nique was used for laparoscopic procedures, as described (IBM, Armonk, New York, USA).
previously2 . Pylorus preservation was attempted wherever
possible in both groups. Any deviation from standard oper- Results
ating techniques was reported by the operating surgeon.
After staging laparoscopy, 32 patients were randomized in
each group (Fig. 1). One patient in the laparoscopic group
Postoperative care had the procedure converted to open surgery, whereas two
After surgery, patients received an infusion of somatostatin patients who were initially allocated to the open group
(SOMASTAT; Solarase, Sun Pharmaceutical Industries, switched to the laparoscopic group as they refused to
Mumbai, India) at 120 μg/h for 3 days, and were observed undergo an open procedure. These patients were retained
in the ICU for 2 days. The decision to move the patient in their original allocated group for the intention-to-treat
out of the ICU was based on clinical improvement. Like- analysis.
wise, fluid management, nutritional support, oral feeds, Baseline characteristics were similar in the two groups
and removal of drains were decided based on the individ- (Table 1). Although PBD was not done routinely, 11
ual patient. Almost all components of enhanced recovery patients in the open group and eight in the laparoscopic
after surgery protocols for pancreatoduodenectomy17 were
incorporated (except with regard to use of somatostatin and
Table 1 Demographic and preoperative data
timing of drain removal, which were done according to
the institutional protocol). Complications, reinterventions Open (n = 32) Laparoscopic (n = 32)
and deaths were recorded. Patients were offered adjuvant Age (years)* 58⋅6(2⋅1) 57⋅8(2⋅0)
chemotherapy, according to final histopathology, and were Sex ratio (M : F) 22 : 10 18 : 14
advised to attend regular follow-up. BMI (kg/m2 )* 22⋅4(0⋅6) 24⋅9(0⋅7)
Co-morbidities‡ 17 15
Haemoglobin (g/dl)* 11⋅8(0⋅3) 11⋅9(0⋅3)
Pathological evaluation Albumin (mg/dl)* 3⋅8(0⋅1) 4⋅0(0⋅1)
Total bilirubin (mg/dl)* 7⋅2(1⋅2) 5⋅0(1⋅0)
The College of American Pathologists protocol18 was used CA19-9 (units/ml)*† 163⋅5(212⋅4) 577⋅2(518⋅1)
for preservation, labelling, processing and reporting of the Preoperative biliary drainage 11 8
ASA grade
specimens. I 11 13
II 18 17
III 3 2
Statistical analysis
*Values are mean(s.d.). †Extreme values excluded. ‡Diabetes mellitus,
The sample size calculation was based on the primary hypertension, asthma, chronic obstructive pulmonary disease,
outcome, length of hospital stay after index surgery until hypothyroidism and heart disease. CA, carbohydrate antigen.
Excluded n = 204
Did not meet inclusion criteria n = 198
Metastatic disease at presentation n = 124
Enrolment
Randomized n = 64
Fig. 1 CONSORT diagram for the trial. PD, pancreatoduodenectomy, ITT, intention to treat
Values are *mean(s.d.) and †median (range). ‡χ2 test, except §Fisher’s exact test, ¶Student’s t test and #Mann–Whitney U test.
group had a drainage procedure, mostly performed by the Duration of surgery was longer for laparoscopic
referring physician. procedures.
The type of pancreatoduodenectomy and related peri- There was one conversion from laparoscopy to open
operative data are summarized in Table 2. Analysis of the surgery, owing to concomitant vascular resection neces-
primary outcome showed that the duration of hospital sitating venous grafting. In total, there were four venous
stay was significantly shorter after laparoscopic compared resections, three in the open group and one in the
with open surgery (Table 2). As regards secondary out- laparoscopic group. Although vascular resection had an
comes, there were significant differences in blood loss impact on operative blood loss, the effect was not statisti-
and transfusion requirement that favoured laparoscopy. cally significant (P = 0⋅071). Subset comparison of blood
loss between the two groups, after exclusion of patients Table 3 Postoperative complications
who had venous resection, confirmed the advantage of Open Laparoscopic
laparoscopy (P = 0⋅003), although it was reduced. (n = 32) (n = 32) P†
Postoperative complications were generally similar in Delayed gastric emptying* 7 5 0⋅603
the two groups. Only the rate of surgical-site infection Pancreatic fistula* 6 5 0⋅311
Grade A 2 3
differed significantly (8 of 32 in open group and 4 of 32
Grade B 3 1
in laparoscopic group; P = 0⋅015) (Table 3). Re-exploration Grade C 1 1
was required in one patient in each group. Postpancreatectomy haemorrhage* 4 3 0⋅396
Grade A 2 1
There was one death in hospital within 90 days in each
Grade B 1 1
group (3 per cent). The patient in the laparoscopic group Grade C 1 1
developed multiple spontaneous perforations involving Postoperative collection 5 4 0⋅860
the small bowel on postoperative day 8, and underwent Surgical-site infection 8 4 0⋅015
Superficial 5 2
re-exploration twice with bowel resection, but died from Deep 3 2
septicaemia and shock. The patient in the open group was Bile leak 2 3 0⋅419
an elderly man who developed portal vein thrombosis that Systemic complications 8 6 0⋅331
Clavien–Dindo grade 10 8 0⋅752‡
was managed with anticoagulation. He deteriorated fur- I 5 3
ther, developing disseminated intravascular coagulation, II 1 2
leading to acute renal failure and death. III 2 2
IV 1 0
V 1 1
Re-exploration 1 1 –
Death 1 1 –
Readmissions Readmission 3 2 0⋅763
During a short follow-up of 90 days, five patients required *According to International Study Group of Pancreatic Surgery
readmission, three in the open and two in the laparoscopic definitions. †Fisher’s exact test, except ‡χ2 test.
group. Reasons were: secondary suturing of the wound (2),
Histopathological analysis
persistent pancreatic fistula (1), aesthenia (1) and recurrent
vomiting due to stomal oedema (gastrojejunostomy) (1). Tumour size and the rate of R0 resection were similar
None of them had evidence of recurrence. in the two groups (Table 4). The mean(s.d.) number of
Values are *mean(s.d.) and †median (range). ‡χ2 test, except §Student’s t test, ¶Mann–Whitney U test and #Fisher’s exact test.
lymph nodes retrieved in the open and laparoscopic groups the present study, there were three venous resections in
were 17⋅0(1⋅4) and 18⋅9(1⋅0) respectively (P = 0⋅063). Nine the open group and one in the laparoscopic group. Con-
patients in the open group and six in the laparoscopic group comitant venous resections represent an important indi-
had perineural invasion (P = 0⋅002), which may reflect later cation for conversion, as was the case here. However, of
in the form of recurrence, or could influence long-term late, studies with a high percentage of venous resections
survival. (17–20 per cent) during laparoscopic procedures have been
reported19,27 .
The mean number of lymph nodes removed was sim-
Discussion
ilar in the laparoscopic and open groups, demonstrating
This randomized trial comparing laparoscopic with open that laparoscopy provides equivalent nodal clearance. Sim-
pancreatoduodenectomy suggested that laparoscopy offers ilar nodal counts have been mentioned by Hakeem and
significant benefit in terms of hospital stay, which was colleagues5 and Croome et al.21 . The R0 resection rate was
the primary outcome of this study. Differences in blood also comparable in the two groups.
loss, transfusion requirements, and wound-related compli- This study has a number of limitations, including the
cations were noted. The laparoscopic approach was sim- small sample size. The study was adequately powered for
ilar to the open procedure regarding other complications analysis of length of hospital stay, but underpowered to
and short-term mortality. The benefits of laparoscopic pan- detect differences in complication rates. Short-term results
creatoduodenectomy in terms of disease-free survival and (90 days) are presented here, but other outcomes were not
long-term survival were not investigated. assessed, such as recurrence and survival (disease-free and
Since the beginning of this decade, several reports5,19 – 23 overall), and long-term complications that become appar-
from other centres have documented comparative data for ent on longer follow-up. As there were more pancreatic
these two procedures. However, until now, no randomized cancers in the open group, this group would be expected to
trial existed. fare worse in terms of disease-specific survival. Finally, the
This study demonstrated a significant advantage for the institutional setting of the present study, with a high case
laparoscopic group in terms of shortened median duration volume and expertise in advanced laparoscopic surgery, and
of postoperative hospital stay, which was decreased by half relatively non-obese patients, probably contributed to low
compared with that of open surgery. Certain other fac- morbidity and mortality rates, and comparable outcomes
tors that can influence length of stay are bile leak, wound in the study groups; the results should therefore be viewed
infection and intra-abdominal collections, as reported by from that perspective, especially with regard to external
others21,24 . The authors believe that the shorter hospital application.
stay can be partly explained by these factors, but was also It is an extremely challenging task to perform a pro-
likely to have been influenced by patients’ perception of cedure like laparoscopic pancreatoduodenectomy safely
major abdominal surgery based on the incision length as and without compromising outcomes. There is an urgent
they were not blinded to the intervention. Mean operat- need for standardization, as the popularity of laparo-
ing times in this study were 320 min for the open group scopic pancreatic resections is rising, and international
and 359 min for the laparoscopic group; although the dif- efforts have been made in the form of guidelines28,29 .
ference is small, it is statistically significant (P = 0⋅041). Further trials with larger numbers of patients are needed
Previous comparative studies19,23 have reported an oper- to clarify the complications and oncological outcomes
ating time for open surgery similar to that in the present with adequate statistical power. The multi-institutional
study, but a longer duration for laparoscopy, which may be pragmatic LEOPARD-2 trial (NTR5689) from the
explained partly by a higher percentage of venous resec- Netherlands and the single-centre PADULAP trial
tions involved. The authors have observed that a com- (ISRCTN93168938) from Spain will possibly contribute
plex procedure like laparoscopic pancreatoduodenectomy further evidence.
has a long learning curve; with experience, the operat-
ing time improved, but then reached a plateau at around Acknowledgements
320–350 min2,16,25 .
The laparoscopic approach was better regarding blood The authors thank V. Kate (Department of Surgery,
loss and transfusion requirements in this study, but the Jawaharlal Institute of Postgraduate Medical Education
difference was less pronounced when procedures with and Research, Pondicherry, India) for critical review and
venous resection were excluded. Similar advantages of suggestions.
decreased blood loss have been reported by others21,26 . In Disclosure: The authors declare no conflict of interest.
preoperative biliary drainage for tumors causing obstructive versus open approaches. J Gastrointest Surg 2015; 19:
jaundice. Ann Surg 2002; 236: 17–27. 189–194.
25 Palanivelu C, Jani K, Senthilnathan P, Parthasarathi R, 28 Hogg ME, Besselink MG, Clavien P-A, Fingerhut A,
Rajapandian S, Madhankumar MV. Laparoscopic Jeyarajah DR, Kooby DA et al.; Minimally Invasive
pancreaticoduodenectomy: technique and outcomes. J Am Pancreatic Resection Organizing Committee. Training in
Coll Surg 2007; 205: 222–230. minimally invasive pancreatic resections: a paradigm shift
26 Langan RC, Graham JA, Chin AB, Rubinstein AJ, Oza K, away from ‘see one, do one, teach one’. HPB (Oxford) 2017;
Nusbaum JA et al. Laparoscopic-assisted versus open 19: 234–245.
pancreaticoduodenectomy: early favorable physical 29 Edwin B, Sahakyan MA, Abu Hilal M, Besselink MG, Braga
quality-of-life measures. Surgery 2014; 156: 379–384. M, Fabre JM et al.; EAES Consensus Conference Study
27 Croome KP, Farnell MB, Que FG, Reid-Lombardo KM, Group. Laparoscopic surgery for pancreatic neoplasms: the
Truty MJ, Nagorney DM et al. Pancreaticoduodenectomy European Association for Endoscopic Surgery clinical
with major vascular resection: a comparison of laparoscopic consensus conference. Surg Endosc 2017; 31: 2023–2041.
Editor’s comments
Laparoscopic and open pancreatoduodenectomy are for the first time studied in a randomized trial, and the authors are
to be congratulated for this effort. The background, rationale and incentives for doing the trial, as well as the choice of
endpoint, will be subject to discussion and interpretation from both its proponents and sceptics. The study showed a
remarkable benefit as it halved the median length of hospital stay in the laparoscopic group, the primary endpoint of the
study. The range of hospital stay did not differ, so laparoscopy can only partially explain this difference. Interpretation
of blood loss and transfusion is troubling as the few patients who had venous resection included confounded these
measures. Morbidity and mortality did not differ, but the study was not powered for this. Most would await long-term
outcomes to conclude robustly on the oncological safety of laparoscopy. However, this trial may not give robust data
on survival as the number of pancreatic cancers was much higher in the open compared with the laparoscopic surgery
group (8 of 32 versus 3 of 32), and will thus influence overall survival. Several new questions arise from this first trial
that need to be addressed before real equivalence, benefit or harm can be stated.
K. Søreide
Editor, BJS